NCT01433913View on ClinicalTrials.gov

Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Interventions
DRUG

metformin hydrochloride

Given PO

OTHER

placebo

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (3)

85724

University of Arizona Health Sciences Center, Tucson

90033

University of Southern California/Norris Cancer Center, Los Angeles

85724-5024

Arizona Cancer Center - Tucson, Tucson

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01433913 - Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter